Gly40Ser polymorphism of the glucagon receptor gene is associated with central adiposity in men

Obesity Research

Volumn 9, Issue 11, 2001, Pages 722-726

  Siani, Alfonso ^a   Iacone, Roberto ^b   Russo, Ornella ^b   Barba, Gianvincenzo ^a   Russo, Paola ^a   Cappuccio, Francesco P ^c   Galletti, Ferruccio ^b   Strazzullo, Pasquale ^b  

^a CNR   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Central adiposity; Epidemiology; Genetics; Waist circumference

Indexed keywords

GLUCAGON RECEPTOR; GLYCINE; LIPID; SERINE;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BLOOD; BODY COMPOSITION; BODY CONSTITUTION; BODY MASS; ENERGY METABOLISM; GENETIC POLYMORPHISM; GENETICS; HETEROZYGOTE; HUMAN; INSULIN RESISTANCE; MALE; MIDDLE AGED; STATISTICAL MODEL;

ADIPOSE TISSUE; ADULT; AGED; BODY COMPOSITION; BODY CONSTITUTION; BODY MASS INDEX; ENERGY METABOLISM; GLYCINE; HETEROZYGOTE; HUMANS; INSULIN RESISTANCE; LIPIDS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, GLUCAGON; SERINE;

EID: 0035516048     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2001.97     Document Type: Article

References (25)

1. Barsh GS, Sadat Farooqi I, O'Rahilly S. Genetics of body weight regulation. Nature. 2000;404:644-51.
2. Pérusse L, Chagnon YC, Weisnagel SJ, et al. The human obesity gene map: the2000 update. Obes Res. 2001;9:135-69.
3. Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Björntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13-year follow-up of participants in the study of men born in 1913. Br Med J. 1984:288:1401-4.
4. Buemann B, Vohl MC, Chagnon M, et al. Abdominal visceral fat is associated with a BcII restriction fragment length polymorphism at the glucocorticoid receptor gene locus. Obes Res. 1997;5:186-92.
5. Ukkola O, Rankinen T, Weisnagel SJ, et al. Interactions among the α2-, β2-, and α3-adrenergic receptor genes and obesity-related phenotypes in the Quebec Family Study. Metabolism. 2000;49:1063-70.
6. Hager J, Hansen L, Vaisse C, et al. A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus. Nat Genet. 1995;9:299-304.
7. Chambers SM, Morris BJ. Glucagon receptor gene mutation in essential hypertension. Nat Genet. 1996;12:122.
8. Brand E, Bankir L, Plouin PF, Soubrier F. Glucagon receptor gene mutation (Gly40Ser) in human essential hypertension: the PEGASE study. Hypertension. 1999;34:15-7.
9. Tonolo G, Melis MG, Ciccarese M, et al. Physiological and genetic characterization of the Gly40Ser mutation in the glucagon receptor gene in the Sardinian population. The Sardinian Diabetes Genetic Study Group. Diabetologia. 1997;40: 89-94.
10. Ristow M, Busch K, Schatz H, Pfeiffer A. Restricted geographical extension of the association of a glucagon receptor gene mutation (Gly40Ser) with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract. 1996;32:183-5.
11. Gerich JE. Physiology of glucagon. Int Rev Physiol. 1981; 24:243-75.
12. Geary N, Le Sauter J, Noh U. Glucagon acts in the liver to control spontaneous meal size in rats. Am J Physiol. 1993; 264:R116-22.
13. Cappuccio FP, Strazzullo P, Farinaro E, Trevisan M. Uric acid metabolism and tubular sodium handling: results from a population-based study. J Am Med Assoc. 1993;270:354-9.
14. Strazzullo P, Iacone R, Siani A, et al. Relationship of the Trp64Arg polymorphism of the β3-adrenoceptor gene to central adiposity and high blood pressure: interaction with age: cross-sectional and longitudinal findings of the Olivetti Prospective Heart Study. J Hypertens. 2001;19:399-406.
15. National Institutes of Health, National Heart, Lung, and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res. 1998;6(suppl 2):51S-209.
16. Kahn HS, Simoes EJ, Koponen M, Hanzlick R. The abdominal diameter index and sudden coronary death in men. Am J Cardiol. 1996;78:961-4.
17. Lahiri DK, Numberger JJ. A rapid non-enzymatic method for preparation of HMW DNA from blood for RFLP studies. Nucleic Acid Res. 1981;19:5444-7.
18. Meigs JB, D'Agostino RB Sr, Wilson PW, Cupples LA, Nathan DM, Singer DE. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes. 1997;46:1594-1600.
19. Kopelman PG. Obesity as a medical problem. Nature. 2000; 404:635-43.
20. Christophe J. Glucagon receptors: from genetic structure and expression to effector coupling and biological responses. Biochim Biophys Acta. 1995;1241:45-57.
21. Hansen LH, Abrahamsen N, Hager J, et al. The Gly40Ser mutation in the human glucagon receptor gene associated with NIDDM results in a receptor with reduced sensitivity to glucagon. Diabetes. 1996;45:725-30.
22. Perea A, Clemente F, Martinell J, Villanueva-Penacarrillo ML, Valverde I. Physiological effect of glucagon in human isolated adipocytes. Horm Metab Res. 1995;27:372-5.
23. Carlson MG, Snead WL, Campbell PJ. Regulation of free fatty acid metabolism by glucagon. J Clin Endocrinol Metab. 1993;77:11-5.
24. Bergman RN, Van Citters GW, Mittelman SD, et al. Central role of the adipocyte in the metabolic syndrome. J Invest Med. 2001;49:119-26.
25. Strazzullo P, Iacone R, Siani A, et al. Altered renal sodium handling and hypertension in men carrying the glucagon receptor gene (Gly40Ser) variant. J Mol Med. 2001. (in press).